Eckert HG - Search Results

1

Murine leukemia induced by retroviral gene marking.

Li Z, Düllmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Wahlers A, Frank O, Ostertag W, Kühlcke K, Eckert HG, Fehse B, Baum C. Li Z, et al. Among authors: eckert hg. Science. 2002 Apr 19;296(5567):497. doi: 10.1126/science.1068893. Science. 2002. PMID: 11964471 No abstract available.

2

Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice.

Carpinteiro A, Peinert S, Ostertag W, Zander AR, Hossfeld DK, Kühlcke K, Eckert HG, Baum C, Hegewisch-Becker S. Carpinteiro A, et al. Among authors: eckert hg. Int J Cancer. 2002 Apr 10;98(5):785-92. doi: 10.1002/ijc.10206. Int J Cancer. 2002. PMID: 11920652

3

Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W. Baum C, et al. Among authors: eckert hg. J Virol. 1995 Dec;69(12):7541-7. doi: 10.1128/JVI.69.12.7541-7547.1995. J Virol. 1995. PMID: 7494260 Free PMC article.

4

Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.

Baum C, Eckert HG, Stocking C, Ostertag W. Baum C, et al. Among authors: eckert hg. Exp Hematol. 1996 Feb;24(2):364-70. Exp Hematol. 1996. PMID: 8641367

5

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.

Hildinger M, Schilz A, Eckert HG, Bohn W, Fehse B, Zander A, Ostertag W, Baum C. Hildinger M, et al. Among authors: eckert hg. Gene Ther. 1999 Jul;6(7):1222-30. doi: 10.1038/sj.gt.3300942. Gene Ther. 1999. PMID: 10455430

6

Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells.

Wahlers A, Schwieger M, Li Z, Meier-Tackmann D, Lindemann C, Eckert HG, von Laer D, Baum C. Wahlers A, et al. Among authors: eckert hg. Gene Ther. 2001 Mar;8(6):477-86. doi: 10.1038/sj.gt.3301426. Gene Ther. 2001. PMID: 11313827

7

Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.

Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W. Baum C, et al. Among authors: eckert hg. J Hematother. 1996 Aug;5(4):323-9. doi: 10.1089/scd.1.1996.5.323. J Hematother. 1996. PMID: 8877707 Review.

8

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.

Fehse B, Uhde A, Fehse N, Eckert HG, Clausen J, Rüger R, Koch S, Ostertag W, Zander AR, Stockschläder M. Fehse B, et al. Among authors: eckert hg. Hum Gene Ther. 1997 Oct 10;8(15):1815-24. doi: 10.1089/hum.1997.8.15-1815. Hum Gene Ther. 1997. PMID: 9358031

9

FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.

Hildinger M, Eckert HG, Schilz AJ, John J, Ostertag W, Baum C. Hildinger M, et al. Among authors: eckert hg. Gene Ther. 1998 Nov;5(11):1575-9. doi: 10.1038/sj.gt.3300759. Gene Ther. 1998. PMID: 9930313

10

Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements.

Ayuk F, Li Z, Kühlcke K, Lindemann C, Schade U, Eckert HG, Zander A, Fehse B. Ayuk F, et al. Among authors: eckert hg. Gene Ther. 1999 Oct;6(10):1788-92. doi: 10.1038/sj.gt.3300999. Gene Ther. 1999. PMID: 10516731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters